tiprankstipranks
Morgan Stanley Adjusts Stake in MorphoSys AG
Company Announcements

Morgan Stanley Adjusts Stake in MorphoSys AG

Morphosys Ag (MOR) has released an update.

Don't Miss our Black Friday Offers:

MorphoSys AG has issued a notification of major holdings, revealing that Morgan Stanley now holds a new total of 6.79% of voting rights, combining direct shares and financial instruments. This change represents a shift from the previous notification, with direct voting rights at 4.43% and voting rights through instruments at 2.36%. The announcement underscores the evolving shareholder landscape of the German biopharmaceutical company.

For further insights into MOR stock, check out TipRanks’ Stock Analysis page.

Related Articles
Ryan AdistIs MOR a Buy, Before Earnings?
TipRanks Auto-Generated NewsdeskMorphoSys AG Finalizes Delisting After Novartis Acquisition
TheFlyOxford Biomedica CFO Stuart Paynter to step down, Lucinda Crabtree to succeed
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App